Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing
Abstract Type VI CRISPR enzymes have been developed as programmable RNA-guided Cas proteins for eukaryotic RNA editing. Notably, Cas13 has been utilized for site-targeted single base edits, demethylation, RNA cleavage or knockdown and alternative splicing. However, the ability to edit large stretche...
Main Authors: | David N. Fiflis, Nicolas A. Rey, Harshitha Venugopal-Lavanya, Beatrice Sewell, Aaron Mitchell-Dick, Katie N. Clements, Sydney Milo, Abigail R. Benkert, Alan Rosales, Sophia Fergione, Aravind Asokan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-46172-4 |
Similar Items
-
Capsid-mediated control of adeno-associated viral transcription determines host range
by: Ezra J. Loeb, et al.
Published: (2024-03-01) -
Understanding and repurposing CRISPR-mediated alternative splicing
by: Jordan L. Smith, et al.
Published: (2018-11-01) -
CRISPR artificial splicing factors
by: Menghan Du, et al.
Published: (2020-06-01) -
CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector
by: Giridhar Murlidharan, et al.
Published: (2016-01-01) -
CRISPR directed evolution of the spliceosome for resistance to splicing inhibitors
by: Haroon Butt, et al.
Published: (2019-04-01)